Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking ...
Over the last 10 months, the Congress government secured agreements for 140 Life Sciences or pharmaceutical projects ...
Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Healthbeat is a newsroom partnership between KFF Health News and Civic News Company that produces reporting on public ... but ...
The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...
BANG Showbiz on MSN48m
Avowed delay was not because Obsidian ‘needed the time’, says Xbox head Phil SpencerXbox boss Phil Spencer has explained 'Avowed's delay to February 2025 was not because Obsidian "needed the time", but was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback